Status | Study |
Completed |
Study Name: A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine Condition: Haemophilus Influenza Date: 2016-02-24 Interventions: Biological: Hib conjugate vaccine Children aged 3-5 months: 3-dose(0,28,56 d);Children aged 6-11 months: |
Recruiting |
Study Name: Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine,Freeze-dried Condition: Haemophilus Influenzae Type b Infections Date: 2015-09-19 Interventions: Biological: Minhai-HIB 0.5ml, |
Completed |
Study Name: Exploratory Clinical Study of MT-2301 Condition: Haemophilus Influenza Type b Date: 2014-05-14 Interventions: Biological: Haemophilus b conjugate vaccine diphteria CRM197 protein conjuga |
Completed |
Study Name: Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children Condition: Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b Date: 2014-05-13 Interventions: Biological: Hib-CRM197 No vacc |
Completed |
Study Name: Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children Condition: Haemophilus Influenzae Type B Infection Date: 2011-07-25 Interventions: Biological: Haemophilus influenza type b conjugate vaccine Primary series is 3 doses given to infants be |
Completed |
Study Name: Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B Condition: Diphtheria Pertussis Tetanus Date: 2011-05-26 Interventions: Biological: Quinvaxem A single dose (0.5 mL) of Quinvaxem |
Completed |
Study Name: Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants Condition: Haemophilus Influenzae Type b (Hib) Infection Date: 2010-10-21 Interventions: Biological: Haemophilus influenzae type b (Hib) vaccine Comparator study of two commercially available H |
Completed |
Study Name: Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children Condition: Haemophilus Influenzae Type b (Hib) Infection Date: 2010-05-14 Interventions: Biological: Monovalent glyco-conjugated vaccine against Haemophilus influenz |
Completed |
Study Name: Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™ Condition: Haemophilus Influenzae Type b Date: 2010-02-02 Interventions: Biological: Tritanrix™-HepB low thio / |
Completed |
Study Name: Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China Condition: Haemophilus Influenzae Type b (Hib) Infection Date: 2010-01-03 Interventions: Biological: Haemophilus influenzae type b (Hib) vaccine Comparator study of two commercially available H |